Results 151 to 160 of about 6,660,257 (317)

A preventive strategy for the control of aphids in sweet pepper using lacewings and micrococcinelid beetles

open access: yesInsect Science, EarlyView.
Aphids pose a serious risk to horticultural crops. Current biocontrol strategies often fail due to the poor establishment of natural enemies when aphids are scarce. We evaluated the potential of two aphidophagous predators, Micromus variegatus and Scymnus interruptus, to be used as preventive biocontrol agents, released before aphid infestation.
Jesica Pérez‐Rodríguez   +3 more
wiley   +1 more source

Iflaviruses in arthropods: when small is mighty

open access: yesInsect Science, EarlyView.
Many arthropod species harbor iflaviruses, which often cause covert (asymptomatic) infections, but may still affect host fitness. We review the impact of iflaviruses on arthropod fitness, immunity, behaviour as well as the iflavirus’ host range, transmission, tissue tropism and the interactions with other microorganisms within arthropods.
Annamaria Mattia   +3 more
wiley   +1 more source

Hemipteran vectors of stylet‐borne plant viruses: Aphids lead the charge

open access: yesInsect Science, EarlyView.
Among all sap‐feeding hemipterans, aphids stand out by far as the most important vectors of noncirculative plant viruses. Compared to whiteflies and mealybugs, aphids’ highly specialized stylet anatomy and distinct feeding behaviors contribute, together with other features of their biology, to their remarkable efficiency in transmitting stylet‐borne ...
Yu Fu, Stefano Colella, Marilyne Uzest
wiley   +1 more source

Ant–aphid mutualism: the influence of Tapinoma ibericum (Hymenoptera: Formicidae) on Aphis gossypii (Hemiptera: Aphidae) control by commercial and spontaneous natural enemies

open access: yesInsect Science, EarlyView.
The mutualism between Tapinoma ibericum ants and Aphis gossypii disrupts the biological control exerted by Aphidius colemani in greenhouse peppers. Ant exclusion increased parasitism and the presence of most natural enemies, although Aphidoletes aphidimyza was more abundant with ants.
Jesús Foronda   +7 more
wiley   +1 more source

Fel d 1‐Expressing Plant‐Derived Bioparticle: A Novel Treatment for Cat Allergy

open access: yesAllergy, EarlyView.
This study investigates the allergenicity and immunogenicity profile of a novel plant‐derived Fel d 1 bioparticle (eBP). Fel d 1 eBP promotes immune tolerance by redirecting allergic Th2 responses toward Th1 and IL‐10–producing regulatory pathways, including Bregs.
Janice A. Layhadi   +16 more
wiley   +1 more source

Rapid generation of prion disease models using AAV‐delivered PrP variants in knockout mice

open access: yesBrain Pathology, EarlyView.
We developed a rapid AAV‐based system to generate prion disease models in weeks rather than months. Following systemic AAV9P31 delivery of modified PrP to knockout mice, we achieved brain‐wide expression and successful propagation of both classical (RML) and atypical (GSS‐A117V) prion strains.
Maitena San‐Juan‐Ansoleaga   +11 more
wiley   +1 more source

small outer capsid protein

open access: yes
Citation: 'small outer capsid protein' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13686 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

The DNA/RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease

open access: yesBrain Pathology, EarlyView.
SIDT2‐immunoreactive inclusions are observed in the striatum, cerebral cortex, and hypothalamus in HD cases with different Vonsattel grades, and the frequency of SIDT2‐immunoreactive inclusions is associated with longer CAG repeats in the huntingtin gene.
Sanaz Gabery   +17 more
wiley   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

The HLA class I immunopeptidomes of AAV capsid proteins. [PDF]

open access: yesFront Immunol, 2023
Brito-Sierra CA   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy